Alicia C. Olivo, EVP, GC & Business Development at NEOGENOMICS INC (NEO), sold 4,918 shares at $10.00 ($49K) on 2025-10-16, disclosed to the SEC on 2025-10-20.
Scheduled sale ($49k) by EVP, GC & Business Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| NEO | SELL | 2024-08-19 | $17K | — | Filing → |
| NEO | SELL | 2024-05-17 | $17K | — | Filing → |
| NEO | SELL | 2024-02-20 | $39K | — | Filing → |